Abstract
Multicenter study of gadopentetate dimeglumine as an MR contrast agent: evaluation in patients with spinal tumors.
G Sze, G K Stimac, C Bartlett, W P Dillon, V M Haughton, W Orrison, F Kashanian and H Goldstein
American Journal of Neuroradiology September 1990, 11 (5) 967-974;
G Sze
Department of Medical Imaging, Memorial Sloan-Kettering Cancer Center, New York, NY 10021.
G K Stimac
Department of Medical Imaging, Memorial Sloan-Kettering Cancer Center, New York, NY 10021.
C Bartlett
Department of Medical Imaging, Memorial Sloan-Kettering Cancer Center, New York, NY 10021.
W P Dillon
Department of Medical Imaging, Memorial Sloan-Kettering Cancer Center, New York, NY 10021.
V M Haughton
Department of Medical Imaging, Memorial Sloan-Kettering Cancer Center, New York, NY 10021.
W Orrison
Department of Medical Imaging, Memorial Sloan-Kettering Cancer Center, New York, NY 10021.
F Kashanian
Department of Medical Imaging, Memorial Sloan-Kettering Cancer Center, New York, NY 10021.
H Goldstein
Department of Medical Imaging, Memorial Sloan-Kettering Cancer Center, New York, NY 10021.

Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Advertisement
G Sze, G K Stimac, C Bartlett, W P Dillon, V M Haughton, W Orrison, F Kashanian, H Goldstein
Multicenter study of gadopentetate dimeglumine as an MR contrast agent: evaluation in patients with spinal tumors.
American Journal of Neuroradiology Sep 1990, 11 (5) 967-974;
Jump to section
Related Articles
- No related articles found.
Cited By...
This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.
Similar Articles
Advertisement